Tbo-filgrastim recalls

The FDA has published 1 recall involving Tbo-filgrastim since 2025. The latest was reported on 12 Feb 2025. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2025

Last 12 months0reported

Class I00% of total

Ongoing1latest 12 Feb 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 1 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why tbo-filgrastim is recalled

Potency & Assay1100%

Companies

Teva Pharmaceuticals USA1100%

By year

20251100%

Ongoing tbo-filgrastim recalls

1 active

Reported	Class	Recall	Company	Reason	Where
12 Feb 2025Drug	CLASS II	Granix (tbo-filgrastim) Injection 300 mcg recalledGranix	Teva Pharmaceuticals USA	Potency & Assay	Nationwide

All tbo-filgrastim recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
12 Feb 2025Drug	CLASS II	Granix (tbo-filgrastim) Injection 300 mcg recalledGranix	Teva Pharmaceuticals USA	Potency & Assay	Nationwide

Should you stop taking Tbo-filgrastim?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.